​

CASI Pharmaceuticals (CASI) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

CASI Stock Forecast

CASI Pharmaceuticals (CASI) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 531.58% increase from the last price of $0.95.

- $1 $2 $3 $4 $5 $6 $7 $8 High: $6 Avg: $6 Low: $6 Last Closed Price: $0.95

CASI Stock Rating

CASI Pharmaceuticals stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

CASI Price Target Upside V Benchmarks

TypeNameUpside
StockCASI Pharmaceuticals531.58%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.95$0.95$0.95
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26-1---1
Jan, 26-1---1
Dec, 25-1---1
Nov, 251----1
Oct, 251----1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 15, 2024Sean LeeH.C. Wainwright$6.00$3.2684.05%531.58%
Aug 15, 2022H.C. Wainwright$12.00$4.02198.51%1163.16%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 15, 2024H.C. WainwrightBuyBuyhold
Nov 16, 2022BTIGBuyBuyhold
Jun 03, 2022BTIGBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.78$-2.89$-2.02-----
Avg Forecast$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
High Forecast$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
Low Forecast$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
Surprise %-8.25%153.51%4.66%-----

Revenue Forecast

$15M $34M $53M $72M $91M $110M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$30.17M$43.11M$33.88M-----
Avg Forecast$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
High Forecast$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
Low Forecast$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
Surprise %0.29%2.44%-6.97%-----

Net Income Forecast

$-45M $-39M $-33M $-27M $-21M $-15M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-37.77M$-39.41M$-26.94M-----
Avg Forecast$-40.53M$-33.37M$-26.96M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
High Forecast$-40.53M$-26.69M$-21.57M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
Low Forecast$-40.53M$-40.04M$-32.35M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
Surprise %-6.80%18.12%-0.08%-----

CASI Forecast FAQ

Is CASI Pharmaceuticals stock a buy?

CASI Pharmaceuticals stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CASI Pharmaceuticals is a favorable investment for most analysts.

What is CASI Pharmaceuticals's price target?

CASI Pharmaceuticals's price target, set by 6 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 531.58% change from the previous closing price of $0.95.

How does CASI Pharmaceuticals stock forecast compare to its benchmarks?

CASI Pharmaceuticals's stock forecast shows a 531.58% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for CASI Pharmaceuticals over the past three months?

  • February 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is CASI Pharmaceuticals’s EPS forecast?

CASI Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2024 is $-2.56, marking a 26.73% increase from the reported $-2.02 in 2023. Estimates for the following years are $-2.13 in 2025, $-1.75 in 2026, $-1.62 in 2027, and $-1.36 in 2028.

What is CASI Pharmaceuticals’s revenue forecast?

CASI Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2024 is $19.8M, reflecting a -41.57% decrease from the reported $33.88M in 2023. The forecast for 2025 is $46.48M, followed by $70.35M for 2026, $89.46M for 2027, and $108.07M for 2028.

What is CASI Pharmaceuticals’s net income forecast?

CASI Pharmaceuticals's net income forecast for the fiscal year ending in December 2024 stands at $-34.202M, representing an 26.97% increase from the reported $-26.938M in 2023. Projections indicate $-28.457M in 2025, $-23.38M in 2026, $-21.644M in 2027, and $-18.17M in 2028.